Sns Financial Group, LLC Gilead Sciences, Inc. Transaction History

Sns Financial Group, LLC

$994 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	BUY	$62.32 - $89.47 $3,552 - $5,099	57 Added 1.4%	4,126 $0
Q3 2022 Oct 12, 2022	BUY	$59.54 - $68.01 $2,500 - $2,856	42 Added 1.04%	4,069 $251,000
Q2 2022 Jul 22, 2022	BUY	$57.72 - $65.01 $2,770 - $3,120	48 Added 1.21%	4,027 $249,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $4,805 - $5,185	-71 Reduced 1.75%	3,979 $278,000
Q2 2021 Aug 02, 2021	BUY	$63.47 - $69.35 $253 - $277	4 Added 0.1%	4,050 $279,000
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $11,460 - $13,075	191 Added 4.95%	4,046 $261,000
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $11,330 - $12,910	200 Added 5.47%	3,855 $225,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $1,242 - $1,561	-20 Reduced 0.54%	3,655 $231,000
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $13,527 - $15,708	-187 Reduced 4.84%	3,675 $283,000
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $17,411 - $22,301	-278 Reduced 6.71%	3,862 $289,000
Q4 2019 Feb 07, 2020	SELL	$61.62 - $67.78 $7,887 - $8,675	-128 Reduced 3.0%	4,140 $269,000
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $4,063 - $4,485	65 Added 1.55%	4,268 $270,000
Q2 2019 Jul 26, 2019	SELL	$61.87 - $69.38 $3,464 - $3,885	-56 Reduced 1.31%	4,203 $284,000
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $26,325 - $29,491	-421 Reduced 9.0%	4,259 $277,000
Q4 2018 Feb 05, 2019	SELL	$60.54 - $79.0 $1.23 Million - $1.6 Million	-20,260 Reduced 81.23%	4,680 $293,000
Q3 2018 Oct 23, 2018	SELL	$71.28 - $78.92 $135,930 - $150,500	-1,907 Reduced 7.1%	24,940 $1.93 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $1,816 - $2,119	-28 Reduced 0.1%	26,847 $1.9 Million
Q1 2018 May 02, 2018	SELL	$72.84 - $88.8 $132,204 - $161,172	-1,815 Reduced 6.33%	26,875 $2.03 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $1.55 Million - $1.81 Million	21,722 Added 311.74%	28,690 $2.06 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $14,422 - $17,094	200 Added 2.96%	6,968 $564,000
Q2 2017 Aug 09, 2017	BUY	N/A	6,768	6,768 $479,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sns Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sns Financial Group, LLC with notifications on news.

Account